Biographical Sketch
Sangeeta Rao Kashyap, MD, is Associate Staff in the Endocrinology and Metabolism Institute at Cleveland Clinic. She is also Assistant Professor of Medicine. She is certified by the American Board of Internal Medicine.
Dr. Kashyap earned her BS in biological sciences from the University of California-Irvine. She completed her medical degree at the University of California at Irvine, and her residency in Internal Medicine at St. Elizabeth’s Medical Center in Boston. She then completed a fellowship in endocrinology, diabetes and metabolism at the Greater Los Angeles VA Medical Center/UCLA and subsequently a postgraduate research fellowship in diabetes at the University of Texas Health Science Center at San Antonio.
Her research interests include insulin resistance and the metabolic syndrome.
Specialty Interests
Diabetes, diabetes and diabetes complications, diabetes mellitus, endocrinology, Gastric Bypass Surgery, hyperlipidemia, insulin resistance and cardiovascular risk prevention, Lipid Disorders, Metabolic Syndrome, metabolism, Obesity, type 1 diabetes
Industry Relationships
Cleveland Clinic physicians and scientists report if they
have any collaborations with the pharmaceutical or medical
device industries as part of the Cleveland Clinic’s
procedures. The Cleveland Clinic publicly discloses
payments to its physicians and scientists for speaking and
consulting of $5,000 or more per year, and any equity,
royalties, and fiduciary relationships in companies with
which they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its doctors’
connections with industry and those of their immediate
family members. As of 7/31/2008,
Dr. Kashyap has reported no financial relationship with
industry that is applicable to this listing. Patients
should feel free to contact their doctor about
relationships with industry and how the relationships are
overseen by the Cleveland Clinic. To learn more about
the Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to our
Integrity in Innovation page.
